Details

Draft guidance document: Identifying and labelling medicinal ingredients in new drug products - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 3, 2026 · edition #6
Timestamp: 2026-01-03T14:48:00.368Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-2.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-6/20260103144800/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-2.html?wbdisable=false#ha_snapshot=447574
ID: 447574
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots